| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/09/2005 | WO2005083110A1 Diagnostics and therapeutics for diseases associated with kallikrein 4 (klk4) |
| 09/09/2005 | WO2005083107A2 Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents |
| 09/09/2005 | WO2005083105A2 Diagnostics and therapeutics for diseases associated with glycogen synthase kinase 3 beta (gsk3b) |
| 09/09/2005 | WO2005083088A1 E.coli o157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 09/09/2005 | WO2005083081A1 Improved nuclease inhibitor cocktail |
| 09/09/2005 | WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof |
| 09/09/2005 | WO2005083071A1 Polynucleotide participating in rheumatoid arthritis and utilization of the same |
| 09/09/2005 | WO2005083070A1 Pharmaceutical composition for lowering blood sugar level |
| 09/09/2005 | WO2005083069A1 Pde2 crystal structures for structure based drug design |
| 09/09/2005 | WO2005083064A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005083063A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005082940A1 Anti-nc1 monoclonal antibody |
| 09/09/2005 | WO2005082933A1 Novel chimeric protein, gene encoding the same, and means of judging leukemia using the gene and the protein |
| 09/09/2005 | WO2005082922A1 Oligonucleotides related to lipid membrane attachments |
| 09/09/2005 | WO2005082409A1 Target for b-cell disorders |
| 09/09/2005 | WO2005082398A2 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells |
| 09/09/2005 | WO2005082234A1 Sensor for measuring an analyte in breath |
| 09/09/2005 | WO2005082135A1 Axon regenration promoter |
| 09/09/2005 | WO2005082095A2 Method and apparatus for measuring properties of concrete |
| 09/09/2005 | WO2005082080A2 Method to modulate the immune system with a novel guanine nucleotide exchange factor |
| 09/09/2005 | WO2005082008A2 Methods for diagnosing and treating bladder cancer |
| 09/09/2005 | WO2005081931A2 Nickel-coated free-standing silicon carbide structure for sensing fluoro or halogen species in semiconductor processing systems, and processes of making and using same |
| 09/09/2005 | WO2005081930A2 Heath monitoring method and apparatus for composite materials |
| 09/09/2005 | WO2005081908A2 Reagents, kits and methods for immunodetection of epitopes on molecules |
| 09/09/2005 | WO2005081783A2 Method for determination and quantification of radiation or genotoxin exposure |
| 09/09/2005 | WO2005081749A2 Neutralizing human antibodies to anthraxtoxin |
| 09/09/2005 | WO2005081721A2 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 09/09/2005 | WO2005081707A2 Methodology and apparatus for the detection of biological substances |
| 09/09/2005 | WO2005081622A1 Methods and compositions for the detection of nitric oxide |
| 09/09/2005 | WO2005071407A3 Methods of diagnosing acute coronary syndrome by measuring urotensin ii |
| 09/09/2005 | WO2005067788B1 Determination of glucose sensitivity and a method to manipulate blood glucose concentration |
| 09/09/2005 | WO2005062050B1 A method for the preparation of ready-to-use solid support for rapid enzyme-linked immunosorbent assay (elisa) |
| 09/09/2005 | WO2005060627A3 Methods of assessing the risk of non-traumatic bone fracture |
| 09/09/2005 | WO2005058957A3 Ztnf 12, a tumor necrosis factor |
| 09/09/2005 | WO2005054866A3 Diagnostics and therapeutics for diseases associated with two-pore domain potassium channel (kcnk2) |
| 09/09/2005 | WO2005052581A3 Spherical and magnetic silicagel carriers having an increase surface for purifying nucleic acids |
| 09/09/2005 | WO2005042760A3 Systems and methods for detecting biological features |
| 09/09/2005 | WO2005040795A3 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepli) |
| 09/09/2005 | WO2005040794A3 Visual indicating device for bad breath |
| 09/09/2005 | WO2005038596A3 Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion |
| 09/09/2005 | WO2005036169A3 Fluorescent probes for ribosomes and method of use |
| 09/09/2005 | WO2005035721A3 Native immunoglobulin binding reagents and methods for making and using same |
| 09/09/2005 | WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 09/09/2005 | WO2005032458A3 Dye solution and method for detecting anhydrous ammonia |
| 09/09/2005 | WO2005030802A3 Antigens for an east coast fever vaccine |
| 09/09/2005 | WO2005028619A3 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
| 09/09/2005 | WO2005020984A3 Method of reducing the risk of oxidative stress |
| 09/09/2005 | WO2005012330A3 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 09/09/2005 | WO2004113513A3 Methods and compositions for modulating stem cell growth and differentiation |
| 09/09/2005 | WO2004094652A3 Zinc-based screening test and kit for early diagnosis of prostate cancer |
| 09/09/2005 | WO2004093822A3 Methods for predicting an individual's clinical treatment outcome from sampling a group of patients' biological profiles |
| 09/09/2005 | WO2004080146A3 A marker system for characterizing undifferentiated human embryonic stem cells |
| 09/09/2005 | WO2004078925A3 Methods and compositions for treating and preventing neurodegenerative diseases |
| 09/09/2005 | WO2004074976A8 Reording medium, playback device, recording method, playback method, and computer program |
| 09/09/2005 | WO2004050835A8 Predicting animal performance |
| 09/09/2005 | WO2004044556A3 Diagnosis of sepsis or sirs using biomarker profiles |
| 09/09/2005 | WO2003086284A3 Colon tumor specific binding peptides |
| 09/09/2005 | WO2003057854A3 Novel proteins and nucleic acids encoding same |
| 09/09/2005 | WO2002010755A9 Organ transplant rejection and associated conditions |
| 09/09/2005 | CA2564612A1 Method, chip, device and system for collection of biological particles |
| 09/09/2005 | CA2558256A1 Oligonucleotides related to lipid membrane attachments |
| 09/09/2005 | CA2558187A1 Method for covalently immobilising biomolecules on organic surfaces |
| 09/09/2005 | CA2558184A1 Detection of a deviation in a material using a spectral camera |
| 09/09/2005 | CA2557559A1 Process and gauge for measuring fiber concentration |
| 09/09/2005 | CA2557549A1 System and method for integrating fluids and reagents in self-contained cartridges containing particle and membrane sensor elements |
| 09/09/2005 | CA2557514A1 Method and apparatus for measuring properties of concrete |
| 09/09/2005 | CA2557503A1 Methods for diagnosing and treating bladder cancer |
| 09/09/2005 | CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/09/2005 | CA2557485A1 Method, chip, device and integrated system for detection biological particles |
| 09/09/2005 | CA2557482A1 Target for b-cell disorders |
| 09/09/2005 | CA2557438A1 Identification of cancer protein biomarkers using proteomic techniques |
| 09/09/2005 | CA2557181A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells |
| 09/09/2005 | CA2557103A1 System and method for the spectroscopic determination of the components and concentrations of pumpable organic compounds |
| 09/09/2005 | CA2557093A1 Cancerous disease modifying antibodies |
| 09/09/2005 | CA2557091A1 Cancerous disease modifying antibodies |
| 09/09/2005 | CA2556925A1 Surrogate markers of neuropathic pain |
| 09/09/2005 | CA2556890A1 Breast cancer prognostics |
| 09/09/2005 | CA2556834A1 Reagents, kits and methods for immunodetection of epitopes on molecules |
| 09/09/2005 | CA2556830A1 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber |
| 09/09/2005 | CA2556817A1 Device and method for the optical evaluation of test strips |
| 09/09/2005 | CA2556559A1 Diagnostic sensor |
| 09/09/2005 | CA2556557A1 Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
| 09/09/2005 | CA2556022A1 Protein phosphorylation in t-cell receptor signaling pathways |
| 09/09/2005 | CA2556021A1 Protein phosphorylation in anaplastic large cell lymphoma |
| 09/09/2005 | CA2556019A1 Protein phosphorylation in c-src signaling pathways |
| 09/09/2005 | CA2555251A1 E.coli o157:h7 c1-1nh-binding protein and methods of use |
| 09/09/2005 | CA2555060A1 Method and device for manipulating liquids in microfluidic systems |
| 09/09/2005 | CA2553957A1 System for the control, verification and recording of the performance of a radioisotope generator's operations |
| 09/09/2005 | CA2553457A1 Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants |
| 09/09/2005 | CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure |
| 09/09/2005 | CA2550151A1 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 09/09/2005 | CA2546641A1 Methodology and apparatus for the detection of biological substances |
| 09/09/2005 | CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands |
| 09/09/2005 | CA2460898A1 Apparatus and method for combining in vivo and in vitro testing |
| 09/08/2005 | US20050198694 Truncated fragments of alpha-synuclein in Lewy body disease |
| 09/08/2005 | US20050197790 Method of determining an analyte concentration in a sample from an absorption spectrum |
| 09/08/2005 | US20050197788 Automatic candidate sequencing system and method |
| 09/08/2005 | US20050197783 Methods and systems for extension, exploration, refinement, and analysis of biological networks |
| 09/08/2005 | US20050197553 Patient management of diabetes treatment |
| 09/08/2005 | US20050197542 Method and a system for determining a physical condition, in particular the apparent age, of at least one region of the body or the face of an individual |